No material signal from this cluster — activity aligns with routine equity compensation management. Traders should monitor for any follow-up open-market sales by additional insiders or changes in guidance.
Price Chart
Executive Summary
Multiple Teva executives, including the CEO, CFO, and other C-suite officers, exercised stock options and received share grants in a routine compensation-related cluster. EVP Matthew Shields conducted open-market sales totaling $547.7K, representing full disposal of shares acquired through option exercises. All other transactions were non-cash events related to equity compensation.
Key Financial Metrics
Key Facts
- EVP Matthew Shields sold 17,295 shares for $547.7K in open-market transactions following option exercises.
- CEO Francis Richard D, CFO Kalif Eliyahu Sharon, and other executives exercised options and received share grants totaling over 300,000 shares, all non-cash events.
- All transactions except Shields' sale were non-cash (codes M, A) and part of standard equity compensation execution.
- Total open-market sales in cluster: $547.7K, representing 0.0015% of Teva's $35.7B market cap — negligible relative to company size.
Financial Impact
$547.7K in open-market sales by one executive; no material financial impact from non-cash transactions
Risk Factors
- Perception risk if media misinterprets option exercise and sale as negative sentiment, though common for executives to sell shares post-exercise for diversification.
- Potential for increased selling pressure if more executives follow similar patterns in coming weeks.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (20 trades, 7d window) | cluster-TEVA-1773086773969 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 10, 2026 22d ago | Press Release | $36.35 $39.19 | ▲ +7.81% | ▲ +8.31% | $39.29 (+8.09%) |
Sep 8, 2026 24d ago | 424B5 | $36.76 $39.25 | ▲ +6.77% | ▲ +7.89% | $39.29 (+6.88%) |
Sep 2, 2026 4w ago | Court Ruling | $37.49 $36.35 | ▼ −3.04% | ▼ −2.08% | $39.29 (+4.80%) |
Aug 28, 2026 5w ago | Press Release | $36.44 $36.36 | ▼ −0.22% | ▼ −0.33% | $39.29 (+7.82%) |
Aug 25, 2026 5w ago | Court Ruling | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.29 (+3.12%) |
Aug 25, 2026 5w ago | Insider Cluster | $38.10 $36.20 | ▼ −4.99% | ▼ −4.46% | $39.29 (+3.12%) |
Aug 10, 2026 7w ago | Insider Cluster | $36.14 $36.46 | ▲ +0.89% | ▲ +0.93% | $39.29 (+8.72%) |
Aug 5, 2026 8w ago | Insider Cluster | $34.81 $36.45 | ▲ +4.70% | ▲ +3.49% | $39.29 (+12.87%) |
Jul 31, 2026 9w ago | Court Ruling | $35.01 $35.36 | ▲ +1.00% | ▼ −2.51% | $39.29 (+12.23%) |
Jul 29, 2026 9w ago | 8-K | $34.71 $34.72 | ▲ +0.03% | ▼ −5.50% | $39.29 (+13.20%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access